Cannabis and Life Science Regulation
3PB’s Cannabis and Life Science team continues to establish itself as a leading light in the life science space, with particular expertise in the fast-evolving cannabis/psychedelics sector.
On the cannabis front, the team provides the measured guidance and advice needed by the cross section of businesses and individuals already involved in, or looking to expand into, the UK’s fast growing medicinal cannabis and CBD product markets. This includes assisting pharmaceutical companies, financiers, regulators, manufacturers, investors, retailers and individuals on the range of issues that face including:
- Obtaining UK or European Market Authorisation
- Contractual issues
- Home Office Controlled Drug licensing requirements
- Industrial Hemp licensing requirements
- The regulatory requirements for the import, storage and export of controlled substances
- Novel foods authorisation
- Advice for those looking to invest into the UK cannabis market
In relation to pharmaceuticals and life science regulation, 3PB’s focus is on industry regulation. It’s members offer advice and representations to companies and investors across the industry including, but not limited to, pharmaceuticals, food and drink, healthcare, veterinary, biotech, medtech, medical devices, vaccines. It can offer support from the conception to sale in areas such as:
- Obtaining UK or European Market Authorisation;
- Classification of medicines
- Conducting clinical trials
- Liability for medical devices
- Regulations concerning marketing and packaging
- Animal testing/issues with the Animals in Science Committee
- MHRA investigations
- Issues arising with the Human Fertilisation and Embryology Authority
As the home of 3PB’s leading education law team, 3PB is well placed to advise university R&D departments on their regulatory issues.
3PB also boasts excellent links with domestic and international law firms advising the sectors who, in turn, are able to offer assistance with issues such as funding arrangements for those looking to invest in the market.
Whilst predominantly advisory based, members of 3PB’s specialist sub team can offer advice and assistance at short notice and are prepared to offer support in writing, in person, over the telephone or video link. Equally, where transactional support is required, members are well versed in the preparation of a wide variety of commercial agreements.
3PB criminal and regulatory barrister Jonathan Underhill joined law firm Mackrell Solicitors and KFP Consulting for an online panel event on 21 May 2021, entitled “Novel Foods – What Now? How to engage with the Regulators” organised for the Cannabis Trades Association and its members. With the FSA still not providing a definitive list of those CBD suppliers / producers who have achieved validation of their novel foods application, Jonathan and the panel looked at...Continue reading
3PB’s specialist regulatory barrister and Head of Trading Standards, Jonathan Underhill will be joining Ricardo Geada, Head of Cannabis and Regulatory Team at Mackrell Law; Siân Phillips, Managing Director at Cannabis Trades Association; and Leon Livermore, Director at KFP consulting to present a webinar on trading standards for the Cannabis Trades Association. The webinar ‘’Novel Foods – What Now? How to engage with the Regulators!’’ will be taking place on Friday 21st May 10am-11am. The...Continue reading
3PB’s Matthew Wyard, a specialist regulatory barrister has issued a briefing, in tandem with Ricardo Geada, head of the cannabis and regulatory team at law firm Mackrell Solicitors aimed at companies working within the CBD industry post-Brexit. As of the 1st January 2021, the UK officially left the EU after a deal was agreed on 24 December. The deal will bring complex changes to the import and export of products for UK businesses, especially those...Continue reading
they are the best in the businessLegal 500